CompletedEarly Phase 1MDMA

Effects of Drugs on Responses to Brain and Emotional Processes

Sponsored by University of Chicago

NCT ID
NCT04053036
Target Enrollment
22 participants
Start Date
2019-08-08
Est. Completion
2021-04-12

About This Study

To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits

Conditions Studied

Autism Spectrum DisorderHealthy

Interventions

  • MDMA
  • Placebo oral tablet

Eligibility

Age:21 Years - 40 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* BMI between 19 and 30 (no one under 130 lbs)
* Smokers smoking less than 25 cigarettes per week
* Have used ecstasy no more than 40 times with no adverse responses.

Exclusion Criteria:

* High blood pressure
* Any medical condition requiring regular medication
* Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis
* Individuals with a history of dependence on stimulant drugs.
* Women who are pregnant or trying to become pregnant

Study Locations (1)

University of Chicago
Chicago, Illinois, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Effects of Drugs on Responses to Brain and Emotional Processes | Huxley